Beyond keeping a close pulse on HAE research and advances from the scientific community, we conduct our own unique research powered by our strong and united community to demonstrate to insurers the quality of life and economic benefits that HAE medicines provide.
With the help of the HAEA, eight HAE therapies have completed clinical trials, received FDA approval, and are now available to treat HAE.
The HAEA continues to actively support all types of novel HAE research, particularly through the US HAEA Angioedema Center at UCSD.
The HAEA takes an active role in patient recruitment for clinical trials. Learn more about ongoing clinical studies in HAE.
We curate a confidential nationwide database of HAE attacks and symptoms, which is the driving force behind new HAE research and discoveries.
